查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1522995

肉毒桿菌市场报告：2030 年趋势、预测与竞争分析

Botulism Illness Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

肉毒桿菌中毒的趋势与预测

预计 2024 年至 2030 年全球肉毒桿菌市场将以 6.6% 的复合年增长率成长。该市场的主要驱动因素是肉毒桿菌中毒发病率的上升和医疗技术领域的进步。全球肉毒桿菌市场的未来看起来充满希望，零售药局市场和网路商店市场也充满机会。

按细分市场分類的肉毒桿菌市场

根据毒素类型、治疗类型、药物分销管道、最终用途和地区对全球肉毒桿菌市场进行预测。

肉毒桿菌市场洞察

Lucintel 预测，A 型肉毒桿菌产品预计将在预测期内强劲成长。

由于处方药和医疗保健产品的广泛使用，零售药局将继续成为该市场的重要组成部分。

由于人们对该疾病的认识不断提高并且先进治疗设施的可用性不断提高，北美在整个预测期内仍将是最大的地区。

常问问题

Q1.市场成长预测是多少：

A1. 2024 年至 2030 年，全球肉毒桿菌市场预计将以 6.6% 的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是：

A2. 该市场的主要驱动因素是肉毒桿菌中毒的流行和医疗技术领域的进步。

Q3.市场的主要细分市场是：

A3. 肉毒桿菌市场的未来性广阔，零售药局和网路商店市场充满机会。

Q4.市场的主要企业是：

A4. 处理肉毒桿菌中毒的主要企业如下：

  • Allergan
  • Pfizer
  • AlphaVax
  • Microbiotix
  • Molecular Targeting Technologies
  • Ipsen Technologies
  • Galderma

Q5.未来最大的细分市场是什么？

A5.Lucintel 预测 A 型肉毒桿菌将在预测期内经历高速成长。

Q6.未来五年预计哪些地区的市场成长最大？

A6. 由于对肉毒桿菌中毒的认识提高以及先进处理设施的容易获得，北美在预测期内仍然是最大的地区。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球肉毒桿菌市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球肉毒桿菌市场趋势（2018-2023）与预测（2024-2030）
  • 按毒素类型分類的全球肉毒桿菌市场
    • A型肉毒桿菌
    • B型肉毒桿菌
  • 按治疗类型分類的全球肉毒桿菌市场
    • 抗毒素
    • 仔细的呼吸道管理
    • 泻药
    • Foley导管
    • 其他的
  • 按药品分销管道分類的全球肉毒桿菌市场
    • 零售药房
    • 网路商店
  • 按最终用途分類的全球肉毒桿菌市场
    • 医院/诊所
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球肉毒桿菌市场
  • 北美肉毒桿菌市场
  • 欧洲肉毒桿菌市场
  • 亚太肉毒桿菌市场
  • 其他区域肉毒桿菌市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按毒素类型分類的全球肉毒桿菌市场成长机会
    • 按治疗类型分類的全球肉毒桿菌市场成长机会
    • 按药品分销管道分類的全球肉毒桿菌市场成长机会
    • 全球肉毒桿菌市场成长机会（依最终用途）
    • 按地区分類的全球肉毒桿菌市场成长机会
  • 全球肉毒桿菌市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球肉毒桿菌市场的产能
    • 全球肉毒桿菌市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Allergan
  • Pfizer
  • AlphaVax
  • Microbiotix
  • Molecular Targeting Technologies
  • Ipsen Technologies
  • Galderma
简介目录

Botulism Illness Trends and Forecast

The future of the global botulism illness market looks promising with opportunities in the retail pharmacy and online store markets. The global botulism illness market is expected to grow with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are rising incidence of botulism and progress in the field of medical technologies.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Botulism Illness by Segment

The study includes a forecast for the global botulism illness by toxin type, treatment type, drug distribution channel, end use, and region.

Botulism Illness Market by Toxin Type [Shipment Analysis by Value from 2018 to 2030]:

  • Botulinum Type A
  • Botulinum Type B

Botulism Illness Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Antitoxins
  • Meticulous Airway Management
  • Cathartics
  • Foley Catheter
  • Others

Botulism Illness Market by Drug Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Pharmacy
  • Online Stores

Botulism Illness Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Others

Botulism Illness Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Botulism Illness Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies botulism illness companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the botulism illness companies profiled in this report include-

  • Allergan
  • Pfizer
  • AlphaVax
  • Microbiotix
  • Molecular Targeting Technologies
  • Ipsen Technologies
  • Galderma

Botulism Illness Market Insights

Lucintel forecasts that botulinum type A is expected to witness higher growth over the forecast period.

Within this market, retail pharmacy will remain larger segment due to widespread accessibility for prescription medication and healthcare products.

North America will remain the largest region over the forecast period due to increasing awareness about the disease and easy availability of advanced treatment facilities in the region.

Features of the Global Botulism Illness Market

Market Size Estimates: Botulism illness market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Botulism illness market size by various segments, such as by toxin type, treatment type, drug distribution channel, end use, and region in terms of value ($B).

Regional Analysis: Botulism illness market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different toxin types, treatment types, drug distribution channels, end uses, and regions for the botulism illness market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the botulism illness market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for botulism illness market?

Answer: The global botulism illness market is expected to grow with a CAGR of 6.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the botulism illness market?

Answer: The major drivers for this market are rising incidence of botulism and progress in the field of medical technologies.

Q3. What are the major segments for botulism illness market?

Answer: The future of the botulism illness market looks promising with opportunities in the retail pharmacy and online store markets.

Q4. Who are the key botulism illness market companies?

Answer: Some of the key botulism illness companies are as follows:

  • Allergan
  • Pfizer
  • AlphaVax
  • Microbiotix
  • Molecular Targeting Technologies
  • Ipsen Technologies
  • Galderma

Q5. Which botulism illness market segment will be the largest in future?

Answer: Lucintel forecasts that botulinum type A is expected to witness higher growth over the forecast period.

Q6. In botulism illness market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing awareness about the disease and easy availability of advanced treatment facilities in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the botulism illness market by toxin type (botulinum type A and botulinum type B), treatment type (antitoxins, meticulous airway management, cathartics, foley catheter, and others), drug distribution channel (retail pharmacy and online stores), end use (hospitals & clinics and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Botulism Illness Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Botulism Illness Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Botulism Illness Market by Toxin Type
    • 3.3.1: Botulinum Type A
    • 3.3.2: Botulinum Type B
  • 3.4: Global Botulism Illness Market by Treatment Type
    • 3.4.1: Antitoxins
    • 3.4.2: Meticulous Airway Management
    • 3.4.3: Cathartics
    • 3.4.4: Foley catheter
    • 3.4.5: Others
  • 3.5: Global Botulism Illness Market by Drug Distribution Channel
    • 3.5.1: Retail Pharmacy
    • 3.5.2: Online Stores
  • 3.6: Global Botulism Illness Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Botulism Illness Market by Region
  • 4.2: North American Botulism Illness Market
    • 4.2.1: North American Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
    • 4.2.2: North American Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
  • 4.3: European Botulism Illness Market
    • 4.3.1: European Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
    • 4.3.2: European Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
  • 4.4: APAC Botulism Illness Market
    • 4.4.1: APAC Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
    • 4.4.2: APAC Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
  • 4.5: ROW Botulism Illness Market
    • 4.5.1: ROW Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
    • 4.5.2: ROW Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Botulism Illness Market by Toxin Type
    • 6.1.2: Growth Opportunities for the Global Botulism Illness Market by Treatment Type
    • 6.1.3: Growth Opportunities for the Global Botulism Illness Market by Drug Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Botulism Illness Market by End Use
    • 6.1.5: Growth Opportunities for the Global Botulism Illness Market by Region
  • 6.2: Emerging Trends in the Global Botulism Illness Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Botulism Illness Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Botulism Illness Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Allergan
  • 7.2: Pfizer
  • 7.3: AlphaVax
  • 7.4: Microbiotix
  • 7.5: Molecular Targeting Technologies
  • 7.6: Ipsen Technologies
  • 7.7: Galderma